European Equities Traded in the US as American Depositary Rise in Wednesday Trading

MT Newswires Live00:12

European equities traded in the US as American depositary receipts were trending higher late Wednesday morning, rising 0.18% to 1,338.75 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by biopharmaceutical company Genfit (GNFT) and electronics conglomerate Philips (PHG), which rose 2.2% and 1.6% respectively. They were followed by financial services companies Banco Santander (SAN) and Banco Bilbao Vizcaya Argentaria (BBVA), which were up 1.4% and 1% respectively.

The decliners from continental Europe were led by biotech firm Evaxion Biotech (EVAX) and biopharmaceutical company DBV Technologies (DBVT), which lost 10% and 3.4% respectively. They were followed by medical device maker EDAP TMS (EDAP) and the pharmaceutical company Sanofi (SNY), which dropped 4.2% and 1.8% respectively.

From the UK and Ireland, the gainers were led by biopharmaceutical companies TC Biopharm (TCBP) and Trinity Biotech (TRIB), which advanced 24.1% and 10.4% respectively. They were followed by biopharmaceutical company Bicycle Therapeutics (BCYC) and pharmaceutical company Mereo BioPharma Group (MREO), which increased 5% and 3.2% respectively.

The decliners from the UK and Ireland were led by biotech firm Autolus Therapeutics (AUTL) and pharmaceutical company AstraZeneca (AZN), which fell 3.4% and 1.6% respectively. They were followed by telecommunications operator Vodafone Group (VOD), which was down 1.5%.

Price: 3.72, Change: +0.08, Percent Change: +2.23

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment